Vanda Pharmaceuticals
VNDA
VNDA
133 hedge funds and large institutions have $633M invested in Vanda Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% less funds holding
Funds holding: 136 → 133 (-3)
3.12% less ownership
Funds ownership: 90.34% → 87.22% (-3.1%)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
Holders
133
Holding in Top 10
4
Calls
$1.89M
Puts
$497K
Top Buyers
| 1 | +$15M | |
| 2 | +$10.5M | |
| 3 | +$10M | |
| 4 |
AC
Armistice Capital
New York
|
+$7.43M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$4.64M |
Top Sellers
| 1 | -$32.2M | |
| 2 | -$8.86M | |
| 3 | -$8.84M | |
| 4 |
Morgan Stanley
New York
|
-$6.69M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$4.04M |